Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 3140-3149

  Saxena, Amit ^a,b,c   Desbois, Sabine ^a,b,c   Carrié, Nadège ^a,b,c   Lawand, Myriam ^a,b,c   Mars, Lennart T ^a,b,c   Liblau, Roland S ^a,b,c  

^a CHU PURPAN   (France)

^b CNRS   (France)

^c France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DIABETOGENESIS; DISEASE COURSE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PLASTICITY; PRIORITY JOURNAL; TC17 CELL; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-17; ISLETS OF LANGERHANS; MICE; MICE, INBRED BALB C; TH1 CELLS; TH17 CELLS; UP-REGULATION;

EID: 84866177899     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103111     Document Type: Article

References (54)

1. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291-297. (Pubitemid 26160699)
2. Bluestone, J. A., K. Herold, and G. Eisenbarth. 2010. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293-1300.
3. + T cells in type 1 diabetes. Adv. Immunol. 100: 79-124.
4. Todd, J. A. 2010. Etiology of type 1 diabetes. Immunity 32: 457-467.
5. Cucca, F., R. Lampis, M. Congia, E. Angius, S. Nutland, S. C. Bain, A. H. Barnett, and J. A. Todd. 2001. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum. Mol. Genet. 10: 2025-2037. (Pubitemid 32998815)
6. Suri, A., J. J. Walters, M. L. Gross, and E. R. Unanue. 2005. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J. Clin. Invest. 115: 2268-2276. (Pubitemid 41135930)
7. Stadinski, B., J. Kappler, and G. S. Eisenbarth. 2010. Molecular targeting of islet autoantigens. Immunity 32: 446-456.
8. Noble, J. A., A. M. Valdes, T. L. Bugawan, R. J. Apple, G. Thomson, and H. A. Erlich. 2002. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum. Immunol. 63: 657-664. (Pubitemid 34816108)
9. Nejentsev, S., J. M. Howson, N. M. Walker, J. Szeszko, S. F. Field, H. E. Stevens, P. Reynolds, M. Hardy, E. King, J. Masters, et al Wellcome Trust Case Control Consortium. 2007. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887-892.
10. Willcox, A., S. J. Richardson, A. J. Bone, A. K. Foulis, and N. G. Morgan. 2009. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155: 173-181.
11. Liblau, R. S., F. S. Wong, L. T. Mars, and P. Santamaria. 2002. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17: 1-6. (Pubitemid 34874613)
12. Seewaldt, S., H. E. Thomas, M. Ejrnaes, U. Christen, T. Wolfe, E. Rodrigo, B. Coon, B. Michelsen, T. W. Kay, and M. G. von Herrath. 2000. Virus-induced autoimmune diabetes: most β-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49: 1801-1809.
13. McKenzie, M. D., N. L. Dudek, L. Mariana, M. M. Chong, J. A. Trapani, T. W. Kay, and H. E. Thomas. 2006. Perforin and Fas induced by IFNγ and TNFa mediate β cell death by OT-I CTL. Int. Immunol. 18: 837-846. (Pubitemid 43983279)
14. Skowera, A., R. J. Ellis, R. Varela-Calviño, S. Arif, G. C. Huang, C. Van-Krinks, A. Zaremba, C. Rackham, J. S. Allen, T. I. Tree, et al. 2008. CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J. Clin. Invest. 118: 3390-3402.
15. + T-cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56: 613-621.
16. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway, Jr. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5: 1026-1031. (Pubitemid 29439573)
17. Lieberman, S. M., A. M. Evans, B. Han, T. Takaki, Y. Vinnitskaya, J. A. Caldwell, D. V. Serreze, J. Shabanowitz, D. F. Hunt, S. G. Nathenson, et al. 2003. Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100: 8384-8388. (Pubitemid 36842554)
18. Amrani, A., J. Verdaguer, P. Serra, S. Tafuro, R. Tan, and P. Santamaria. 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406: 739-742.
19. Liu, S. J., J. P. Tsai, C. R. Shen, Y. P. Sher, C. L. Hsieh, Y. C. Yeh, A. H. Chou, S. R. Chang, K. N. Hsiao, F. W. Yu, and H. W. Chen. 2007. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-β and interleukin-6. J. Leukoc. Biol. 82: 354-360.
20. + T cells lacking T-bet and eomesodermin. Science 321: 408-411.
21. Curtis, M. M., S. S. Way, and C. B. Wilson. 2009. IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. J. Immunol. 183: 381-387.
22. Hamada, H., Mde. L. Garcia-Hernandez, J. B. Reome, S. K. Misra, T. M. Strutt, K. K. McKinstry, A. M. Cooper, S. L. Swain, and R. W. Dutton. 2009. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J. Immunol. 182: 3469-3481.
23. + Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 39: 1716-1725.
24. Yen, H. R., T. J. Harris, S. Wada, J. F. Grosso, D. Getnet, M. V. Goldberg, K. L. Liang, T. C. Bruno, K. J. Pyle, S. L. Chan, et al. 2009. Tc17 CD8 T cells: functional plasticity and subset diversity. J. Immunol. 183: 7161-7168.
25. + T cells. J. Immunol. 182: 5296-5305.
26. + T cells in hepatocellular carcinoma patients. J. Immunol. 185: 1544-1549.
27. Orgun, N. N., M. A. Mathis, C. B. Wilson, and S. S. Way. 2008. Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells. J. Immunol. 180: 4109-4115.
28. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
29. Tajima, M., D. Wakita, D. Noguchi, K. Chamoto, Z. Yue, K. Fugo, H. Ishigame, Y. Iwakura, H. Kitamura, and T. Nishimura. 2008. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+T cells. J. Exp. Med. 205: 1019-1027. (Pubitemid 351679678)
30. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155. (Pubitemid 351186376)
31. Caruso, R., D. Fina, O. A. Paoluzi, G. Del Vecchio Blanco, C. Stolfi, A. Rizzo, F. Caprioli, M. Sarra, F. Andrei, M. C. Fantini, et al. 2008. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur. J. Immunol. 38: 470-478.
32. Res, P. C., G. Piskin, O. J. de Boer, C. M. van der Loos, P. Teeling, J. D. Bos, and M. B. Teunissen. 2010. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE 5: e14108.
33. Yeh, N., N. L. Glosson, N. Wang, L. Guindon, C. McKinley, H. Hamada, Q. Li, R. W. Dutton, P. Shrikant, B. Zhou, et al. 2010. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J. Immunol. 185: 2089-2098.
34. + Th17 mediate costimulation blockade-resistant allograft rejection in T-betdeficient mice. J. Immunol. 181: 3906-3914.
35. He, D., L. Wu, H. K. Kim, H. Li, C. A. Elmets, and H. Xu. 2006. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177: 6852-6858. (Pubitemid 44715050)
36. + interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 48: 4153-4161.
37. + T cells display enhanced antitumor immunity. Blood 114: 596-599.
38. Marwaha, A. K., S. Q. Crome, C. Panagiotopoulos, K. B. Berg, H. Qin, Q. Ouyang, L. Xu, J. J. Priatel, M. K. Levings, and R. Tan. 2010. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J. Immunol. 185: 3814-3818.
39. + T cells. Eur. J. Immunol. 22: 1013-1022.
40. Cabarrocas, J., J. Bauer, E. Piaggio, R. Liblau, and H. Lassmann. 2003. Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 33: 1174-1182. (Pubitemid 36609135)
41. + single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34.
42. Saxena, A., J. Bauer, T. Scheikl, J. Zappulla, M. Audebert, S. Desbois, A. Waisman, H. Lassmann, R. S. Liblau, and L. T. Mars. 2008. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181: 1617-1621.
43. Piaggio, E., L. T. Mars, C. Cassan, J. Cabarrocas, M. Hofstätter, S. Desbois, E. Bergereau, O. Rötzschke, K. Falk, and R. S. Liblau. 2007. Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance. Proc. Natl. Acad. Sci. USA 104: 9393-9398. (Pubitemid 47185790)
44. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
45. Kim, S. H., M. M. Cleary, H. S. Fox, D. Chantry, and N. Sarvetnick. 2002. CCR4-bearing T cells participate in autoimmune diabetes. J. Clin. Invest. 110: 1675-1686. (Pubitemid 35424246)
46. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Holländer, and L. Piali. 2002. β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 8: 1414-1420. (Pubitemid 36024137)
47. McGeachy, M. J., Y. Chen, C. M. Tato, A. Laurence, B. Joyce-Shaikh, W. M. Blumenschein, T. K. McClanahan, J. J. O'Shea, and D. J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10: 314-324.
48. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397. (Pubitemid 350138974)
49. Vizler, C., N. Bercovici, A. Heurtier, N. Pardigon, K. Goude, K. Bailly, C. Combadière, and R. S. Liblau. 2000. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J. Immunol. 165: 6314-6321.
50. Bromley, S. K., S. Y. Thomas, and A. D. Luster. 2005. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6: 895-901. (Pubitemid 43090444)
51. + T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. Int. Immunol. 23: 751-759.
52. Bending, D., H. De la Peña, M. Veldhoen, J. M. Phillips, C. Uyttenhove, B. Stockinger, and A. Cooke. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119: 565-572.
53. Boniface, K., W. M. Blumenschein, K. Brovont-Porth, M. J. McGeachy, B. Basham, B. Desai, R. Pierce, T. K. McClanahan, S. Sadekova, and R. de Waal Malefyt. 2010. Human Th17 cells comprise heterogeneous subsets including IFN-γ-producing cells with distinct properties from the Th1 lineage. J. Immunol. 185: 679-687.
54. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.